Find clinical trials for Breast Cancer in London, England
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near London, England, GBR:
The purpose of this study is to find out how effective the combination of crizotinib and fulvestrant is in shrinking lobular breast cancer...
Phase 2
London, United Kingdom and 4 other locations
adjuvant systemic treatment instead of adjuvant chemotherapy followed by endocrine therapy in older patients with stage II-III ER+/HER2- early breast...
Phase 2
London, United Kingdom and 72 other locations
This neoadjuvant trial for patients with TNBC and/or gBRCA breast cancer, aims to investigate the safety and efficacy (improvement ...
Phase 2, Phase 3
London, United Kingdom and 29 other locations
This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...
Phase 3
London, Greater London, United Kingdom and 226 other locations
DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with o ...
Phase 1, Phase 2
Buckhurst Hill, United Kingdom and 71 other locations
The aim of this study is to assess the rates of circulating tumour DNA (ctDNA) in patients treated with surgery for stage 1 breast cancer...
London, United Kingdom and 1 other location
This study will be conducted in patients with metastatic breast cancer who have specific Fibroblast Growth Factor Receptor gene abn...
Phase 2
London, England, United Kingdom and 36 other locations
A Phase 1 Dose Escalation and Expansion Study of AZD9833 Alone or in Combination in Women with ER Positive, HER2 Negative Advanced Breast Ca...
Phase 1
London, United Kingdom and 16 other locations
be investigating how effective the combination is for a subgroup of breast cancer patients whose cancer expresses the andr...
Phase 1
London, United Kingdom and 7 other locations
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....
Phase 3
London, London, CITY OF, United Kingdom and 324 other locations
Clinical trials
Research sites
Resources
Legal